Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P-F Pradat

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of Neuro-Oncology|January 5, 2000
Treatment of meningeal gliomatosisP F Pradat, K Hoang-Xuan, P Cornu, et al.
AJNR. American Journal of Neuroradiology|November 11, 2017
Spinal Cord Gray Matter Atrophy in Amyotrophic Lateral SclerosisM-Ê Paquin, M M El Mendili, C Gros, et al.
Human Gene Therapy|January 10, 2002
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathiesP F Pradat, P Kennel, S Naimi-Sadaoui, et al.
European Journal of Neurology|June 7, 2017
Spinal cord multi-parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosisG Querin, M M El Mendili, T Lenglet, et al.
Revue Neurologique|June 20, 2002
[Nocturnal oxymetry in patients with amyotrophic lateral sclerosis: role in predicting survival]R Velasco, F Salachas, E Munerati, et al.
European Journal of Neurology|July 17, 2019
Adaptive functional reorganization in amyotrophic lateral sclerosis: coexisting degenerative and compensatory changesM Abidi, G de Marco, A Couillandre, et al.
Gene Therapy|September 12, 2002
Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathyP-F Pradat, P Kennel, S Naimi-Sadaoui, et al.
Revue Neurologique|July 13, 2020
Botulinum toxin therapy improves masseter spasticity in Amyotrophic Lateral SclerosisM Mongin, R Debs, N Le Forestier, et al.
Brain : a Journal of Neurology|September 26, 2001
Does primary lateral sclerosis exist? A study of 20 patients and a review of the literatureN Le Forestier, T Maisonobe, A Piquard, et al.
Revue Neurologique|November 14, 2025
Markers of presymptomatic amyotrophic lateral sclerosis: State of the art, practical implications and perspectivesM-H Soriani, H Blasco, P Corcia, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Neuro-Oncology|January 5, 2000
Treatment of meningeal gliomatosisP F Pradat, K Hoang-Xuan, P Cornu, et al.
AJNR. American Journal of Neuroradiology|November 11, 2017
Spinal Cord Gray Matter Atrophy in Amyotrophic Lateral SclerosisM-Ê Paquin, M M El Mendili, C Gros, et al.
Human Gene Therapy|January 10, 2002
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathiesP F Pradat, P Kennel, S Naimi-Sadaoui, et al.
European Journal of Neurology|June 7, 2017
Spinal cord multi-parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosisG Querin, M M El Mendili, T Lenglet, et al.
Revue Neurologique|June 20, 2002
[Nocturnal oxymetry in patients with amyotrophic lateral sclerosis: role in predicting survival]R Velasco, F Salachas, E Munerati, et al.
European Journal of Neurology|July 17, 2019
Adaptive functional reorganization in amyotrophic lateral sclerosis: coexisting degenerative and compensatory changesM Abidi, G de Marco, A Couillandre, et al.
Gene Therapy|September 12, 2002
Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathyP-F Pradat, P Kennel, S Naimi-Sadaoui, et al.
Revue Neurologique|July 13, 2020
Botulinum toxin therapy improves masseter spasticity in Amyotrophic Lateral SclerosisM Mongin, R Debs, N Le Forestier, et al.
Brain : a Journal of Neurology|September 26, 2001
Does primary lateral sclerosis exist? A study of 20 patients and a review of the literatureN Le Forestier, T Maisonobe, A Piquard, et al.
Revue Neurologique|November 14, 2025
Markers of presymptomatic amyotrophic lateral sclerosis: State of the art, practical implications and perspectivesM-H Soriani, H Blasco, P Corcia, et al.
Pageof 5